A California woman was motivated to embark on a 3,000-mile walk to raise awareness of the power of healthy living. Judy ...

A pause to NIH funding has researchers scrambling for contingency plans at the University of Washington’s Alzheimer’s Disease Research Center. The center’s brain bank is preserving more than 4,000 ...

As more people get an early diagnosis, they face the difficult decision about when and how to reveal their condition.

But the exact mechanisms of how the drug works in the brain in doing things like tamping down food noise, addiction, and now, ...

As the Trump administration makes cuts to federal health agencies, some Alzheimer's experts are worried about the impact on ...

A mountain region in Colombia was an epicenter of early-onset Alzheimer’s.. One researcher saw an opportunity to discover the ...

Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, ...

Senolytics are considered an anti-aging medication, and they’re currently used to treat a range of health conditions. And new ...

The European Commission on Tuesday authorized the use of Eisai and Biogen's drug to treat mild cognitive impairment in the early stages of Alzheimer's disease.

A new AI Alzheimer's detection tool can listen to voice recordings and accurately determine if you'll develop the disease.

GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.